Topic: Health

Scientists have found three existing medications that may help treat or prevent Alzheimer's disease. These medicines were initially developed to treat other conditions, but researchers think they could be used to protect the brain from Alzheimer's.

Alzheimer's is a leading cause of death in the UK, affecting over one million people. In fact, one in three people born today will develop dementia in their lifetime. Currently, there is no cure for Alzheimer's. Creating new drugs can take 10 to 15 years and cost billions of pounds, with no guarantee of success. That's why scientists are exploring a faster, safer, and more affordable path: repurposing existing medicines.

A team of researchers from the University of Exeter, led by Dr. Anne Corbett, examined 80 existing medications to see which ones could be used to treat or prevent Alzheimer's disease. They looked for drugs that target biological processes linked to Alzheimer's, have shown encouraging results in cell and animal studies, and are considered safe for use in older adults.

The three priority candidates selected were the shingles vaccine (Zostavax), Viagra (sildenafil), and a medication used to treat motor neurone disease (riluzole). The shingles vaccine showed the strongest signal, with previous research suggesting that people who received the vaccine were about 16% less likely to develop dementia. Researchers hope to launch a large UK clinical trial of the shingles vaccine.

The study was published in Alzheimer's Research and Therapy and was funded by the Alzheimer's Society and other organizations. The researchers believe that repurposing existing medicines could provide a faster, safer, and more affordable path toward new Alzheimer's treatments.

Why It Matters

This research matters to Indian students because it highlights the importance of thinking creatively about how we can solve complex problems like Alzheimer's disease. By repurposing existing medicines, scientists may be able to find new ways to treat or prevent this devastating condition, which affects millions of people worldwide.

Key Facts

• The three priority candidates selected for further research were the shingles vaccine (Zostavax), Viagra (sildenafil), and a medication used to treat motor neurone disease (riluzole).
• The shingles vaccine showed the strongest signal, with previous research suggesting that people who received the vaccine were about 16% less likely to develop dementia.
• The study was published in Alzheimer's Research and Therapy and was funded by the Alzheimer's Society and other organizations.
• Creating new drugs can take 10 to 15 years and cost billions of pounds, with no guarantee of success.

Key Terms

Repurposing

Using an existing medicine for a different condition or purpose.

Implications

This research matters to Indian students because it highlights the importance of thinking creatively about how we can solve complex problems like Alzheimer's disease. By repurposing existing medicines, scientists may be able to find new ways to treat or prevent this devastating condition, which affects millions of people worldwide.